Cargando…

The increasing expression of GPX7 related to the malignant clinical features leading to poor prognosis of glioma patients

BACKGROUND: Glioma is the most common malignant brain tumor in adults. The standard treatment scheme of glioma is surgical resection combined alternative radio- and chemotherapy. However, the outcome of glioma patients was unsatisfied. Here, we aimed to explore the molecular and biological function...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yao, Jiawei, Chen, Xin, Liu, Zhendong, Zhang, Ruotian, Zhang, Cheng, Yang, Quan, Yao, Penglei, Jiang, Qiuyi, Wu, Jianing, Zhao, Shiguang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7945363/ https://www.ncbi.nlm.nih.gov/pubmed/33750478 http://dx.doi.org/10.1186/s41016-021-00235-3

Ejemplares similares

Identification of hub genes and small-molecule compounds related to intracerebral hemorrhage with bioinformatics analysis
por: Liu, Zhendong, et al.
Publicado: (2019)

Identification of hub genes and small-molecule compounds in medulloblastoma by integrated bioinformatic analyses
por: Liu, Zhendong, et al.
Publicado: (2020)

Abnormal expression of HOXD11 promotes the malignant behavior of glioma cells and leads to poor prognosis of glioma patients
por: Wang, Jialin, et al.
Publicado: (2021)

The overexpression of GPX8 is correlated with poor prognosis in GBM patients
por: Li, Sibo, et al.
Publicado: (2022)

An Immune Gene-Related Five-lncRNA Signature for to Predict Glioma Prognosis
por: Wang, Xinzhuang, et al.
Publicado: (2020)

Significantly high expression of NUP37 leads to poor prognosis of glioma patients by promoting the proliferation of glioma cells
por: Liu, Zhendong, et al.
Publicado: (2021)

Interleukin-1 receptor-associated kinase 4 as a potential biomarker: Overexpression predicts poor prognosis in patients with glioma
por: Wang, Jialin, et al.
Publicado: (2021)

GPX7 Is Targeted by miR-29b and GPX7 Knockdown Enhances Ferroptosis Induced by Erastin in Glioma
por: Zhou, Yan, et al.
Publicado: (2022)

COL4A1 as a novel oncogene associated with the clinical characteristics of malignancy predicts poor prognosis in glioma
por: Wang, Hongbo, et al.
Publicado: (2021)

A Bioinformatic Analysis: The Overexpression and Prognostic Potential of GPX7 in Lower-Grade Glioma
por: Zhao, Qianqian, et al.
Publicado: (2022)

Overexpression of FRAT1 Is Associated with Malignant Phenotype and Poor Prognosis in Human Gliomas
por: Guo, Geng, et al.
Publicado: (2015)

Decreased let-7b is associated with poor prognosis in glioma
por: Zhang, Wanzeng, et al.
Publicado: (2019)

Interfering with hyaluronic acid metabolism suppresses glioma cell proliferation by regulating autophagy
por: Yan, Tao, et al.
Publicado: (2021)

Overexpression of GINS4 is associated with poor prognosis and survival in glioma patients
por: Liu, Binfeng, et al.
Publicado: (2021)

Overexpressed XRCC2 as an independent risk factor for poor prognosis in glioma patients
por: Liu, Zhendong, et al.
Publicado: (2021)

Positive Expression of Retinol-Binding Protein 4 Is Related to the Malignant Clinical Features Leading to Poor Prognosis of Glioblastoma
por: Deng, Xinqing, et al.
Publicado: (2022)

ITGB3BP is a potential biomarker associated with poor prognosis of glioma
por: Liu, Zhendong, et al.
Publicado: (2021)

14-3-3β exerts glioma-promoting effects and is associated with malignant progression and poor prognosis in patients with glioma
por: Liu, Liang, et al.
Publicado: (2018)

CMTM6 overexpression is associated with molecular and clinical characteristics of malignancy and predicts poor prognosis in gliomas
por: Guan, Xiudong, et al.
Publicado: (2018)

GPX8 as a Novel Prognostic Factor and Potential Therapeutic Target in Primary Glioma
por: Yang, Zhao-shou, et al.
Publicado: (2022)

Intra-tumoral angiogenesis correlates with immune features and prognosis in glioma
por: Zhang, Qing, et al.
Publicado: (2022)

Positive ALDH1A3 and Negative GPX3 Expressions Are Biomarkers for Poor Prognosis of Gallbladder Cancer
por: Yang, Zhu-lin, et al.
Publicado: (2013)

GPX3 Overexpression in Cumulus Cells Entails a Poor Prognosis for Uterine Implantation of Morphotype A Embryos
por: Bejarano, Ignacio, et al.
Publicado: (2022)

ESPL1 Is a Novel Prognostic Biomarker Associated With the Malignant Features of Glioma
por: Liu, Zhendong, et al.
Publicado: (2021)

DRAXIN as a Novel Diagnostic Marker to Predict the Poor Prognosis of Glioma Patients
por: Jia, Yulong, et al.
Publicado: (2022)

High co‐expression of SLC7A11 and GPX4 as a predictor of platinum resistance and poor prognosis in patients with epithelial ovarian cancer
por: Wu, Xiaodong, et al.
Publicado: (2022)

GPX4 and GPX7 Over-Expression in Human Hepatocellular Carcinoma Tissues
por: Guerriero, E., et al.
Publicado: (2015)

PDIA5 is Correlated With Immune Infiltration and Predicts Poor Prognosis in Gliomas
por: Zhang, Hao, et al.
Publicado: (2021)

c-Fos over-expression promotes radioresistance and predicts poor prognosis in malignant glioma
por: Liu, Zhi-Gang, et al.
Publicado: (2016)

Comprehensive analysis of epigenetics regulation, prognostic and the correlation with immune infiltrates of GPX7 in adult gliomas
por: Ferreira, Wallax Augusto Silva, et al.
Publicado: (2022)

MAGOH is correlated with poor prognosis and is essential for cell proliferation in lower-grade glioma
por: Xiao, Feng, et al.
Publicado: (2023)

The predictive role of the neutrophil–lymphocyte ratio in the prognosis of adult patients with stroke
por: Wan, Jinzhao, et al.
Publicado: (2020)

The Effect of GPX2 on the Prognosis of Lung Adenocarcinoma Diagnosis and Proliferation, Migration, and Epithelial Mesenchymal Transition
por: Li, Yu-peng, et al.
Publicado: (2022)

Secretory Pathway Kinase FAM20C, a Marker for Glioma Invasion and Malignancy, Predicts Poor Prognosis of Glioma
por: Du, Shaonan, et al.
Publicado: (2020)

High level of miR-221/222 confers increased cell invasion and poor prognosis in glioma
por: Zhang, Chunzhi, et al.
Publicado: (2012)

GNG5 is a novel oncogene associated with cell migration, proliferation, and poor prognosis in glioma
por: Zhang, Wang, et al.
Publicado: (2021)

EZH2 overexpression is associated with poor prognosis in patients with glioma
por: Zhang, Yanyang, et al.
Publicado: (2016)

KLF11 Expression Predicts Poor Prognosis in Glioma Patients
por: Xi, Zhuo, et al.
Publicado: (2021)

MGME1 associates with poor prognosis and is vital for cell proliferation in lower-grade glioma
por: Xiao, Feng, et al.
Publicado: (2023)

Overexpression of CDCA8 promotes the malignant progression of cutaneous melanoma and leads to poor prognosis
por: Ci, Chao, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_8gluc0m9r16ec7i9t79m51dp1u